Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm Keane

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
American Journal of Hematology|March 3, 2009
Aspergillus flavus sinusitis in ALLColm Keane, Michael Colreavy, Maureen Lynch, et al.
British Journal of Haematology|December 17, 2008
Myeloid and lymphoid neoplasm with FGFR1 abnormalityColm Keane, Andrea Henden, Tony Mills, et al.
Ejhaem|July 9, 2025
T-Cell Receptor Repertoires Show Dynamic Variation Between Diagnosis and Relapse of Diffuse Large B-Cell LymphomaJoel Wight, Tom Witkowski, Colm Keane, et al.
Current Opinion in Immunology|December 28, 2023
Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironmentLouisa F Alim, Colm Keane, Fernando Souza-Fonseca-Guimaraes
Haematologica|November 6, 2025
Advances in biomarkers for mantle cell lymphoma in the era of targeted therapiesZoe Loh, Paul Yeh, Colm Keane, et al.
Cancers|November 14, 2023
Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin LymphomaArina Martynchyk, Rakin Chowdhury, Eliza A Hawkes, et al.
British Journal of Haematology|February 12, 2019
Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directionsCharlotte Lees, Colm Keane, Maher K Gandhi, et al.
Cells|June 2, 2021
PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell LymphomaJoshua W D Tobin, Karolina Bednarska, Ashlea Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Reply to M. SorigueJoshua W D Tobin, Colm Keane, Jay Gunawardana, et al.
American Journal of Hematology|March 6, 2013
CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapyColm Keane, Devinder Gill, Frank Vari, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|March 3, 2009
Aspergillus flavus sinusitis in ALLColm Keane, Michael Colreavy, Maureen Lynch, et al.
British Journal of Haematology|December 17, 2008
Myeloid and lymphoid neoplasm with FGFR1 abnormalityColm Keane, Andrea Henden, Tony Mills, et al.
Ejhaem|July 9, 2025
T-Cell Receptor Repertoires Show Dynamic Variation Between Diagnosis and Relapse of Diffuse Large B-Cell LymphomaJoel Wight, Tom Witkowski, Colm Keane, et al.
Current Opinion in Immunology|December 28, 2023
Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironmentLouisa F Alim, Colm Keane, Fernando Souza-Fonseca-Guimaraes
Haematologica|November 6, 2025
Advances in biomarkers for mantle cell lymphoma in the era of targeted therapiesZoe Loh, Paul Yeh, Colm Keane, et al.
Cancers|November 14, 2023
Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin LymphomaArina Martynchyk, Rakin Chowdhury, Eliza A Hawkes, et al.
British Journal of Haematology|February 12, 2019
Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directionsCharlotte Lees, Colm Keane, Maher K Gandhi, et al.
Cells|June 2, 2021
PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell LymphomaJoshua W D Tobin, Karolina Bednarska, Ashlea Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Reply to M. SorigueJoshua W D Tobin, Colm Keane, Jay Gunawardana, et al.
American Journal of Hematology|March 6, 2013
CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapyColm Keane, Devinder Gill, Frank Vari, et al.
Pageof 7